A股異動 | 中來股份(300393.SZ)升超7% 投建年產2GW高效N型光伏組件項目
格隆匯9月13日丨中來股份(300393.SZ)拉昇漲超7%,報15.6元有望挑戰歷史高價,成交額放大至12.3億元,總市值達170億元。中來股份12日公吿,根據公司戰略規劃,公司控股子公司泰州中來全資子公司鄂爾多斯中來擬在內蒙古鄂爾多斯市東勝區投資建設“年產2GW高效N型光伏組件項目”,此次擬先行建設項目一期1GW,該1GW項目投資總額預計2億元(部分設備將以泰州中來現有部分設備資產出資。另外,公司1.5GW電池項目爭取於今年10月份逐步投產,1.5GW項目建成投產後,加上公司原有的2.1GW年產能,合計將形成3.6GW年產能。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.